Skip to main content
. 2014 Apr;12(2):280–286. doi: 10.2450/2013.0022-13

Table II.

Indications for red cell genotyping.

Appropriate Possible Not feasible at this time
Chronically-transfused patient* Haematology-oncology patient Surgical patient
Patient with multiple alloantibodies Oncology patient (non-haematological) Trauma patient at presentation
Patient with autoimmune haemolytic anaemia Patient with a single blood group alloantibody All transfused patients
Patient with an alloantibody to a high prevalence antigen Donor and recipient in hematopoietic progenitor cell transplantation
Foetus in a mother with an alloantibody Patient with advanced renal failure
Search for donors with rare phenotypes Patient with advanced hepatic failure
Sample with a phenotyping discrepancy or difficulty
Reagent red blood cell development and testing
*

For example, one with sickle cell disease, thalassaemia, myelodysplastic syndrome, or aplastic anaemia;

consider buccal swaps in some situations;

intrauterine foetal transfusions matched to the mother’s antigens to prevent further alloimmunisation.